Boston Scientific (BSX) Akcija Kursas
Boston Scientific Kursas
Pajamos augo 5,1 % per metus per pastaruosius 19 metus iki 20,07 mlrd. USD. Pelnas akcijai augo 14,1 % per metus per pastaruosius 14 metus. Boston Scientific grynoji marža dabar yra 14,4 %, išaugo nuo 8,7 % prieš kelerius metus. Analitikų tikslinės kainos mediana yra 50,50 USD, t. y. virš dabartinę kainą 17,5 %. Iš 37 analitikų 24 rekomenduoja pirkti — bendras konsensusas yra Pirkti.
Boston Scientific akcijos kaina
Gaukite šiuos duomenis per Eulerpool API
100 000 užklausų/mėn. nemokamai · be kortelės
Boston Scientific akcija ir akcijų analizė
Dažnai užduodami klausimai apie Boston Scientific akciją
The main competitors of Boston Scientific Corp in the market include Medtronic, Johnson & Johnson, Abbott Laboratories, and Edwards Lifesciences.
Boston Scientific Corp is a global medical technology company. Its business model revolves around developing innovative medical solutions that enhance patient care and healthcare outcomes. Boston Scientific Corp manufactures and markets a broad range of medical devices used in various specialties, such as cardiology, urology, endoscopy, and neuromodulation. The company's commitment to research and development enables it to introduce advanced technologies and therapies that address unmet clinical needs. Boston Scientific Corp also focuses on collaborations and partnerships to expand its product portfolio, improve access to healthcare, and provide high-quality medical devices to patients worldwide.
Boston Scientific Corp is primarily active in the medical equipment and supplies industry.
Boston Scientific Corp is a renowned medical technology company based in Marlborough, Massachusetts. Established in 1979, it has become a global leader in the development, manufacturing, and marketing of innovative medical devices. With a focus on advancing patient care, Boston Scientific Corp offers a wide range of products for various medical specialties, including interventional cardiology, urology, endoscopy, and neuromodulation. The company's history showcases its commitment to medical breakthroughs and improving the lives of patients worldwide. Boston Scientific Corp's dedication to cutting-edge technology and strategic acquisitions has allowed it to maintain a prominent position in the healthcare industry.
Boston Scientific Corp has achieved significant milestones throughout its history. Some notable achievements include the development of the Taxus Express, a groundbreaking drug-eluting stent that revolutionized the treatment of coronary artery disease. Additionally, the acquisition of Guidant Corporation strengthened Boston Scientific's position in the field of cardiac rhythm management. The company's innovative products, such as the Watchman Left Atrial Appendage Closure device, have provided improved treatment options for patients with atrial fibrillation. Boston Scientific Corp continues to innovate and make advancements in medical technologies, helping to improve patient outcomes worldwide.
Boston Scientific Corp is primarily present in several countries and regions worldwide. The company has a strong global presence, with significant operations in the United States, Europe, Asia-Pacific, Latin America, and the Middle East. Its diverse market reach spans across more than 130 countries, enabling Boston Scientific Corp to provide innovative medical solutions and technologies to a vast range of patients and healthcare professionals worldwide.
Boston Scientific Corp represents values of innovation, collaboration, and patient-centricity. With a strong corporate philosophy focused on improving patients' lives, the company is committed to developing and delivering innovative medical solutions. Boston Scientific Corp's dedication to collaboration extends to its partnerships with healthcare professionals and institutions, helping to address unmet needs and improve patient outcomes. By prioritizing patient-centric care, the company ensures that its products and services are designed to provide effective and meaningful treatments. Boston Scientific Corp's continued commitment to innovation and collaboration underscores its mission to transform lives through medical advancements in a rapidly evolving healthcare landscape.
Analitikai šiuo metu nustato vidutinę Boston Scientific akcijos tikslinę kainą 53,77 USD (mediana: 50,50 USD), t. y. +25,1 % palyginti su paskutine kaina. Konsensusas pagrįstas 37 analitikų reitingais.
37 analitikai šiuo metu vertina Boston Scientific akciją: 24 rekomenduoja pirkti, 12 laikyti ir 1 parduoti. 2026 m. analitikai tikisi, kad Boston Scientific gaus 20,97 mlrd. USD pajamų ir 3,14 USD pelno akcijai.
Pagal dabartinį kursą Boston Scientific akcija kainuoja 39,15 EUR (42,99 USD).
Boston Scientific akcija (BSX) kotiruojama 10 biržose, įskaitant: NYSE (BSX), London (0HOY.L), SIX (Zürich) (BSX.SW), XETRA (BSX.DE), Frankfurt (BSX.F), München (BSX.MU), Düsseldorf (BSX.DU), Wien (BSXC.VI).
The Boston Scientific Corporation is a medical technology company that specializes in the manufacturing and development of medical devices. The company was founded in Massachusetts in 1979 and operates globally today. Its business model includes various divisions that focus on different medical specialties. The Cardiac Rhythm Management division of Boston Scientific is involved in the manufacturing of devices for the treatment of heart rhythm disorders. This includes products such as implantable defibrillators, pacemakers, and accessories. The products in this division are of high quality and have an excellent track record in treating patients with severe heart problems. The Interventional Cardiology division of Boston Scientific specializes in the manufacturing of products used in the treatment of heart diseases. This includes balloon catheters, stents, and catheter ablation systems. These products are typically minimally invasive and allow for a quick restoration of normal heart rhythm in patients. The Interventional Radiology division of Boston Scientific is focused on the manufacturing of products for the diagnosis and treatment of vascular diseases. The company produces catheters, stents, and embolization accessories, among other things. Additionally, Boston Scientific is also specialized in the development of products for the treatment of chronic pain. The products in this division include implantable pain therapy systems, neurostimulators, and accessories. These devices can alleviate patients' pain and improve their quality of life. The company is also specialized in the field of urology, including products for the treatment of conditions such as urinary incontinence and benign prostatic hyperplasia. Boston Scientific produces mesh implants and devices aimed at improving bladder control. Furthermore, the company has a division dedicated to gastrointestinal diseases, including products for the treatment of conditions like colorectal cancer and gastrointestinal bleeding. The portfolio includes endoscopes, balloon catheters, and other devices for the treatment of digestive tract disorders. Boston Scientific is committed to providing its customers with the best products. Product development is strongly focused on meeting the needs of patients and doctors. By continually developing new products, the company can expand its market position and maintain its leading position in the medical technology industry.
tikėtina pelnas Boston Scientific yra 20,97 mlrd. USD. Šis skaičius grindžiamas dabartiniais finansiniais duomenimis ir atspindi įmonės verslo rezultatus.
tikėtina grynasis pelnas Boston Scientific yra 4,69 mlrd. USD. Grynasis pelnas atspindi įmonės pelningumą po visų išlaidų atimties.
Kainų ir nuomos santykis (KGV) Boston Scientific šiuo metu yra 13,71. KGV lygina dabartinę akcijos kainą su pelnu už akciją ir padeda investuotojams įvertinti Boston Scientific akcijos vertę.
Kainų ir pardavimų santykis (KUV) Boston Scientific šiuo metu yra 3,07. KUV lygina rinkos kapitalizaciją su metinėmis pajamomis ir yra Boston Scientific akcijos įvertinimo metrika.
Eulerpool kokybės balas Boston Scientific yra 5/10.
Boston Scientific ISIN yra US1011371077. ISIN (International Securities Identification Number) yra pasaulinė unikali vertybinių popierių identifikacijos sistema.
Boston Scientific WKN yra 884113. WKN (Wertpapierkennnummer) yra šešiaženklė vokiška vertybinių popierių identifikacijos sistema.
Boston Scientific prekybos žymė yra BSX. Ši biržos žymė naudojama Boston Scientific akcijoms prekiauti biržoje.
Boston Scientific akcija
Boston Scientific Pagrindiniai konkurentai
Boston Scientific Biržos simbolis
Boston Scientific FIGI
Visos Boston Scientific pagrindinės charakteristikos ir giluminė analizė
Mūsų akcijų analizė Boston Scientific akcijai apima svarbius finansinius rodiklius, tokius kaip apyvarta, pelnas, P/E santykis, P/S santykis, EBIT, taip pat informaciją apie dividendes. Be to, mes nagrinėjame aspektus, tokius kaip akcijos, rinkos kapitalizacija, skolos, nuosavas kapitalas ir įsipareigojimai Boston Scientific. Jei ieškote išsamesnės informacijos šiais klausimais, mūsų poskyriuose galite rasti išsamias analizes:





